Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cancer Pain × Oxycodone × Clear all

Phase

Status

Completed 8 Not yet recruiting 2 Unknown 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 2 Neoplasms 2 Lung Neoplasms 1 Cancer Pain 1

Interventions

Pharmaceutical Services 2 Lidocaine 2 Ethanol 2 Acetaminophen 2 Venlafaxine Hydrochloride 1 Telemedicine 1 Ropivacaine 1 Radiofrequency Ablation 1 Pregabalin 1 Oxycodone 1 Morphine 1 Methadone 1 Memantine 1 Ketamine 1 Hospitals 1 Gels 1 Cholecalciferol 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808531 2022-04-12

NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

Medlab Clinical

Phase 3 Unknown

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡